ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.

Zoya Qureshy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.